Recent News

• 01.28.2025 - DKN-01 DeFianCe and DisTinGuish Data Update - Q1 2025
• 01.28.2025 - Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study
• 01.15.2025 - 43rd Annual J.P. Morgan Healthcare Conference
• 01.06.2025 - Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
• 12.04.2024 - Piper Sandler 36th Annual Healthcare Conference
• 11.26.2024 - Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference
• 11.13.2024 - Leap Therapeutics Reports Third Quarter 2024 Financial Results

Recent Filings

• 01.28.2025 - EX-99.1 EX-99.1
• 01.28.2025 - 8-K Current report
• 11.15.2024 - 4 Statement of changes in beneficial ownership of securities
• 11.14.2024 - SC 13G Statement of Beneficial Ownership by Certain Investors
• 11.13.2024 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.06.2024 - S-8 Securities to be offered to employees in employee benefit plans
• 10.31.2024 - SC 13D/A General Statement of Acquisition of Beneficial Ownership